Form 8-K - Current report:
SEC Accession No. 0001558370-22-010269
Filing Date
2022-06-24
Accepted
2022-06-24 16:27:40
Documents
13
Period of Report
2022-06-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20220621x8k.htm   iXBRL 8-K 79237
2 EX-10.1 tmb-20220621xex10d1.htm EX-10.1 7900
  Complete submission text file 0001558370-22-010269.txt   213213

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20220621.xsd EX-101.SCH 3061
4 EX-101.LAB tmb-20220621_lab.xml EX-101.LAB 16019
5 EX-101.PRE tmb-20220621_pre.xml EX-101.PRE 10426
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220621x8k_htm.xml XML 4854
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 221040443
SIC: 2834 Pharmaceutical Preparations